Efficacy of contraceptive methods: a review of the literature

D Mansour, P Inki… - The European Journal of …, 2010 - Taylor & Francis
Objectives To provide a comprehensive and objective summary of contraceptive failure rates
for a variety of methods based on a systematic review of the literature. Methods Medline and …

The oral contraceptive pill: a revolution for sportswomen?

K Bennell, S White, K Crossley - British journal of sports medicine, 1999 - bjsm.bmj.com
OBJECTIVES: To determine the effects of the oral contraceptive pill (OCP) on skeletal
health, soft tissue injury, and performance in female athletes. METHODS: A literature review …

An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest

F Fruzzetti, F Trémollieres, J Bitzer - Gynecological Endocrinology, 2012 - Taylor & Francis
Natural estrogens such as estradiol (E2) or its valerate ester (E2V) offer an alternative to
ethinyl estradiol (EE). E2-containing combined oral contraceptives (COCs) have …

The physiology of the highly trained female endurance runner

M Burrows, S Bird - Sports Medicine, 2000 - Springer
Continuing improvements in the performance of female endurance runners and increasing
levels of participation have generated the need to know more about the physiology of this …

Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label …

J Endrikat, S Parke, D Trummer, W Schmidt, I Duijkers… - Contraception, 2008 - Elsevier
BACKGROUND: Attempts to improve the tolerability of combined oral contraceptives (COCs)
have included the substitution of ethinylestradiol (EE) with 17β-estradiol (E2). However, this …

Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest

S Zeun, M Lu, A Uddin, B Zeiler… - The European Journal …, 2009 - Taylor & Francis
Objective To evaluate the pharmacokinetics of a combined oral contraceptive (OC)
containing oestradiol valerate/dienogest (E2V/DNG) administered according to a four-phasic …

Review of clinical experience with estradiol in combined oral contraceptives

F Fruzzetti, J Bitzer - Contraception, 2010 - Elsevier
Previous attempts to replace ethinylestradiol (EE) with 17β-estradiol (E2) in combined oral
contraceptives (COCs) have proved unsatisfactory in terms of bleeding outcomes. A review …

An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel on hemostatic, lipids …

J Endrikat, C Klipping, M Cronin, C Gerlinger, A Ruebig… - Contraception, 2002 - Elsevier
In this open label, randomized study we compared the influence of a dose-reduced oral
contraceptive containing 20 μg ethinyl estradiol (EE) and 100 μg levonorgestrel (20 EE) with …

A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 μg ethinyl estradiol combined …

SO Skouby, J Endrikat, B Düsterberg, W Schmidt… - Contraception, 2005 - Elsevier
OBJECTIVES: To evaluate the impact on lipid and carbohydrate variables of a combined
one-third ethinyl estradiol (EE)/levonorgestrel (LNG) dose reduction in oral contraceptives …

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 …

J Endrikat, U Müller, B Düsterberg - Contraception, 1997 - Elsevier
The aim of this study was to compare contraceptive reliability, cycle control, and tolerance of
an oral contraceptive containing 20 μg ethinylestradiol (EE2) and 75 μg gestodene (GSD) …